Renal Denervation: FDA Panel, Industry Mostly on the Same Page

Renal Denervation: FDA Panel, Industry Mostly on the Same Page

Source: 
MedPage
snippet: 

Industry seems to have learned from early mistakes with renal denervation, as development for device-based hypertension treatment appears to be headed in line with expectations of an FDA advisory panel.